Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
23 authors at 14 institutions in 1 country.
Alberto FresaSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0002-8084-9009
Francesco AutoreDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-7868-7469
Alfonso PiciocchiGruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
Gioacchino CataniaDivision of Hematology, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.ORCID 0000-0002-1743-9525
Andrea VisentinHematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.ORCID 0000-0003-0271-7200
Annamaria TomassoSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Marina MorettiReparto di Oncoematologia Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.ORCID 0000-0003-1161-9995
Candida VitaleUniversity Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.ORCID 0000-0002-2592-8724
Annalisa ChiarenzaDivision of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
Francesca MorelliDepartment of Hematology, Università degli Studi di Firenze, Florence, Italy.
Paolo SportolettiCentro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.ORCID 0000-0002-5630-9862
Roberto MarascaHematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0002-6431-6878
Giuseppe SapienzaDivision of Oncohematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.ORCID 0000-0002-0149-0764
Annarosa CuccaroHematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy.ORCID 0000-0002-0237-1839
Roberta MurruHematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, Italy; and.
Alessandro SannaDepartment of Hematology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Caterina PattiDivision of Oncohematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
Ilaria AngelettiReparto di Oncoematologia Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
Marta CosciaUniversity Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Livio TrentinHematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.ORCID 0000-0003-1222-6149
Daniela PietrasantaDivision of Hematology, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Idanna InnocentiDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-7290-260X
Luca LaurentiSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0002-8327-1396
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo · ITAzienda Ospedaliera S.Maria · ITOspedale Vincenzo Cervello · ITUniversity of Padua · ITAzienda Ospedaliero-Universitaria Careggi · ITAzienda Usl Toscana Centro · ITFondazione Gimema Onlus · ITUniversity of Catania · ITUniversity of Florence · ITUniversity of Modena and Reggio Emilia · ITUniversity of Perugia · IT
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. · full record | OpenQuestion